BIOtech Now George Goodno This week in Geneva three key UN agencies are meeting to address and advance their shared mission of achieving the UN Sustainable Development Goals. This is the seventh technical symposium organized by the WHO, WIPO and WTO dedicated to achieving the ambitious goals of UN Sustainable Development Goal 3: Ensure healthy […]
BIOtech Now Jim Greenwood Over the last decade, I’ve become increasingly conscious of maintaining my cardiovascular health, making dietary changes and keeping my blood pressure and cholesterol levels in check. Heart disease is preventable and taking sensible steps can help a person dodge the number one killer in our country. It’s true that heart disease […]
BIOtech Now George Goodno It is an underreported fact that the time it takes for a generic medicine to come to market has remained steady at approximately 13.5 years for over two decades. And, once entering the market, generics are acquiring greater market share, faster than ever before. That’s why BIO is releasing its a new […]
BIOtech Now Joe Hansen This past March, BIO launched DrugCostFacts.org, an interactive web tool designed to help policymakers, members of the media and the broader public access the best facts surrounding drug costs, spending and value. By featuring a series of commonly asked questions, as well as research and reading materials, BIO created a one-stop shop […]
BIOtech Now Andrew Segerman DNA defines who we are. And like anything else, sometimes there are mistakes – mutations in genes that can cause life-lasting conditions. But what if broken genes could be repaired? How many patients could we help in the years ahead? This is the promise and possibility of genome editing. In 2017, […]
BIOtech Now Andrew Segerman Opioid abuse and addiction is one of the worst public health crises America has ever faced. The solution, however, has never been clearer: innovation can help get our nation back on track. In an op-ed published today by Morning Consult, Dr. Jeremy Levin, Chairman and CEO of Ovid Therapeutics outlines three […]
BIOtech Now Daniel Seaton Opioid addiction is plaguing communities across the country, leaving in its wake countless victims, devastated families and economic ruin. Long-term solutions to combating this crisis will depend upon biomedical innovation and the development of novel and safer, next generation therapies to treat both pain and addiction. Exploring the challenges involved in […]
BIOtech Now Brian Newell It’s a first-of-its-kind gene therapy ever approved by the U.S. Food and Drug Administration, marking yet another critical milestone in the era of modern medicine. Known as Luxturna, the treatment was developed by Spark Therapeutics to tackle a rare genetic defect that leads to one devastating outcome: total blindness. Jeffrey Marrazzo, […]
BIOtech Now Andrew Segerman Imagine that it is 2AM and the pain is so severe that you cannot move. At this point, driving is not an option, so you call an ambulance assuming they know the fastest route to the emergency room. Thankfully, you have insurance to help cover the costs – or so you […]
BIOtech Now Andrew Segerman Everyday it’s a new headline. The numbers keep rising. No, we’re not talking about the latest lottery jackpot. We’re talking about one of the worst flu seasons in nearly 10 years. But it’s not too late to protect yourself with a flu vaccine – and here’s why you should: “The negatives […]
BIOtech Now Andrew Segerman In 1992, with the support of the biopharmaceutical industry, Congress created the 340B Drug Discount Program to help uninsured and vulnerable patients gain access to affordable prescription drugs. Over the years, however, there have been growing signs that this program has expanded well past the intent of Congress and that patients […]
BIOtech Now Jim Greenwood Africa is known for its diverse cultures, expansive landscapes, dramatic coastlines, luscious forests and exotic wildlife. Much less is known about the continent’s rising cancer epidemic, but it’s all too real. Shockingly, 60 percent more Africans die from cancer today than from malaria. Africa is home to several of the world’s […]
BIOtech Now Jim Greenwood It’s been 25 years since Congress created the 340B Drug Discount Program, a program designed to provide uninsured and vulnerable patients with access to better health care and more affordable prescription drugs. As part of the law, drug manufacturers provide substantial discounts on outpatient medicines and treatments to select health care […]
BIOtech Now admin Editor’s Note: As part of BIO’s 25th Anniversary celebration we will be spotlighting biotechnology innovations that have made a major impact over the past 25 years. This “Innovation Series” will publish on the 25th of every month throughout 2018. We kick-off this month with personalized medicine. One size does not fit all when it […]
BIOtech Now Andrew Segerman Here’s a statistic you might not have known: an estimated 700,000 people die each year due to the growing number of infections resistant to treatment. Known as antimicrobial resistance (AMR), this “silent killer” and looming public health threat has severe social and economic consequences that could have a lasting impact on […]
BIOtech Now Andrew Segerman Since 2006, the Medicare prescription drug program – known as Medicare Part D – has provided America’s seniors and disabled individuals with access to a wide range of affordable medicines. By relying on market-based competition, this program has achieved substantial savings for taxpayers and helped provide affordable medicines to our most […]
BIOtech Now Jim Greenwood If you’re an adult living in the United States, there’s a 95-percent change you’ve had chickenpox. Unfortunately, as we age, we run the risk of reactivating that virus, varicella zoster, in the form of shingles. If you contract the chickenpox virus, you will carry it for the rest of your life. […]
BioTechniques News Gut bacteria play essential roles in developing and regulating normal immune responses. Can they also help treat autoimmune diseases? Full BioTechniques Article here Powered by WPeMatico
BioTechniques News Using a variant of CRISPR technology, scientists made a precise change to correct a genetic disorder in human embryos. Full BioTechniques Article here Powered by WPeMatico
BIOtech Now Andrew Segerman We’ve been saying it for some time, and the numbers speak for themselves: spending on prescription drugs is heading in the right direction – there’s no denying it. Drug prices increased by only 1% over the last year — that’s before factoring in manufacturers rebates and discounts. And data from Prime Therapeutics […]